MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
          • Virtual Tour
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Medical Writing and Submission
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Global Data Operations
      • Clinical Data Management
      • Biostatistics Services
      • Clinical MetaData Repository (MDR)
    • Medical Writing Solutions
    • Quantitative Clinical Development Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics and Biological Sample Lifecycle Management Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Regulatory and Clinical Technology
      • Regulatory Information Management
        • LIQUENT InSight®
        • Regulatory Cloud
        • Regulatory Outsourcing Services
      • Data-Driven Monitoring
      • Clinical Trial Management System (CTMS)
        • IMPACT® CTMS Software
      • Electronic Data Capture
        • DataLabs® EDC
      • MyTrials® Analytics
    • Patient Technology
      • Randomization and Trial Supply Management
        • Clinical Trial Supplies & Logistics
        • Clinical Trial Supply Chain - Active Tracking
        • ClinPhone RTSM Mobile App
      • Medical Imaging
        • Therapeutic Expertise
          • Oncology Imaging Expertise
            • Criteria Experience
              • 1996 NCI-WG CLL
              • IWCLL 2008
                • Key Topics: IWCLL 2008
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • B symptoms
                  • Blood Counts
                  • Bone Marrow
                  • Transformation
                  • Role of Imaging in CLL Clinical Trials
                  • Clinical Data Assessments
              • 1999 IWG-NHL
              • 2007 IWG-NHL
                • Key Topics: 2007 IWG-NHL Assessment Criteria
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • Bone Marrow
                  • Other Laboratory Values and Symptoms
                  • Incorporation of FDG-PET
                  • Defining Normal, Abnormal and Measurable
                  • Problem with CRu
              • RECIST
          • Neurology Imaging Expertise
          • Musculoskeletal (MSK) Imaging Expertise
          • Women's Health Imaging Expertise
          • Dermatology Imaging Expertise
          • Gastroenterology Imaging Expertise
          • Ophthalmology Imaging Expertise
          • Volumetric Imaging Expertise
          • Cardiovascular Imaging Expertise
        • Imaging Services
        • Scientific Advisors
        • Consultation
        • Advanced Medical Imaging
          • Cloud-Based Solutions for Sites
      • Patient Sensors
      • Electronic Clinical Outcome Assessments (eCOA)
        • ePRO (electronic Patient Reported Outcomes)
        • Clinical Outcome Assessments Consulting
    • Clinical Trial Supplies & Logistics
    • Perceptive® Cloud
    • Asset Transfer Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT InSight® Training
        • Courses & Registration
          • LIQUENT InSight® for Submission Management
            • LIQUENT InSight®Submission Planning and Tracking
          • LIQUENT SmartDesk™
            • Automating the Publishing Process with LIQUENT SmartDesk™ for PDF
          • LIQUENT InSight for Viewing
            • Reviewing Submissions with LIQUENT InSight® for Viewing
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Other Training Services
    • Customer Care Services
  • Consulting
    • Integrated Product Development
      • A Biosimilar Milestone with Implications
    • Regulatory Compliance & Risk Management
      • Q&A about GCP
        • Quality By Design Putting Theory Into Practice
      • Strategic Compliance: Data Integrity
      • FDA 483s: Your Questions Answered
      • Important Reminder About PET (Positron Emitting Topography) FDA Regulations
      • Quality By Design Putting Theory Into Practice
    • Regulatory Outsourcing Services
      • eCTD
    • Regulatory Information Management & IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
    • Market Access Consulting
  • Access
    • Real World Evidence
      • Late Phase Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
    • Outsourced Field-Based Medical Teams
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • PAREXEL® BioPharm Unit
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Global Data Operations
      • Medical Writing Solutions
      • Quantitative Clinical Development Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Regulatory and Clinical Technology
      • Patient Technology
      • Clinical Trial Supplies & Logistics
      • Perceptive® Cloud
      • Asset Transfer Services
      • PAREXEL's Education Services
      • Customer Care Services
    • Consulting
      • Integrated Product Development
      • Regulatory Compliance & Risk Management
      • Regulatory Outsourcing Services
      • Regulatory Information Management & IDMP Solutions
      • Market Access Consulting
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
      • Outsourced Field-Based Medical Teams
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
    • PAREXEL® BioPharm Unit
  • Company
    • Management Team
      • Jamie Macdonald
      • Roland Andersson, Ph.D.
      • Michael Crowley
      • Xavier Flinois
      • Michele Fournier
      • David J. Godwin
      • Simon Harford
      • Sy Pretorius, M.D.
      • Gadi Saarony
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
    • PAREXEL Reports U.K. Gender Pay Data
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • About
    • Locations
    • FAQs
    • Agenda
  • RWE Symposia
    • About
    • Locations
    • FAQs
    • Agenda
  • Graduate | PAREXEL
    • Culture at PAREXEL
    • Former Trainees at PAREXEL
      • Career Trainee Meghan
      • Career Trainee Sam
    • Great Place to Work
    • PAREXEL Overview
    • Clinical Trainee Program Belgium
    • Clinical Trainee Program Japan
    • Graduate Scheme India
    • Clinical Research Awards
    • Graduate Scheme UK
  • parexel-insights
    • When It Comes to CTMS One Size Does Not Fit All
    • This Disease Will Not Win the Fight
    • Designing Trials Payers Can Trust
    • Utilizing Secondary Healthcare Data Assets
    • RIM & IDMP Synergies
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • 'Now is the time to include Japan' says PAREXEL
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Developing Drugs in the New Era of Personalized Medicines
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Imaging Endpoint Selection For Biosimilar Development
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • Protocol Optimization
    • New Approaches to Data Management in Clinical Trials
    • 30 Years Later: Lessons from Living in a Pandemic
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Involved & Engaged: The Last Mile of Business Performance
    • Adaptive Trials: Complex But Advantageous
    • Grateful for Advancements in Medicine
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Orphan Drug Pricing in Europe
    • Generating Evidence to Drive Patient Access
    • Life is Short and Love is Eternal
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • A People Strategy Attracts the Best Talent
    • Clinical Development of Next Generation Biologics
    • Best Practices to Improve the IRT Site User Experience
    • If You Never Stop Learning, You Can Never Stop Earning
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Focused on the Finish Line
    • Using Analytics to Optimize The Clinical Development Process
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • Immuno-Oncology: Past, Present and Future
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • World Cancer Day: Reflecting on Progress and Hope for Patients
    • Progress in Pursuit of a Cure - World AIDS Day 2017
    • How Performance Reviews Support High-Performance Talent
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Overcoming Data Capture and Management Challenges
    • Running with a Purpose
    • Three Keys To Mitigating Risk In Adaptive Trials
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • Key Considerations In Biologics Clinical Development
    • Data Management Roles, Process and Technologies in Risk Based Study Execution
    • Recorded Webinar: Getting to Approval Faster Through Technology Innovation
    • Attitude is Everything
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Your clinical trial supply may be at risk – Brexit and the impact on IMP distribution
    • You’re Hot Then You’re Cold -Temperature Management & RTSM Integration
    • Precision Medicine’s Next Hurdle: Quality Management of Human Samples
    • Genomic Medicine, Data Modeling and Clinical Trials
    • Dragons - the Guardians of Disease
    • Recognizing Uncle David
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Increasing Study Predictability
    • Demonstrating Value and Managing Risk Throughout Development
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • Navigating Regulatory Submissions
    • Get Into Pole Position with Modern IRT Services
    • Quantitative Modeling For Clinical Trials
    • PAREXEL Celebrates International Women's Day 2018
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • Drew Garty Discusses Data Driven Monitoring
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • Want Your Business to Thrive? Focus on Developing Your People
    • Rooting for Team Jessie
    • Anything is Possible
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • The Next Generation of Talent Management: Opportunities For Diversity
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • What You Need To Know About Biosimilars Development
    • Improving Site Experience with Risk-Based Monitoring
    • Aligning on Patient Outcomes – How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies
    • Accelerated Pathways and Stock Prices
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Navigating Regulatory Complexities Of Biosimilar Development
    • Wearables Shaping the Future of Clinical Trials
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • Why Strategy is Not Enough: Building the Bridge From Strategy to Results Requires Organizational Excellence
    • Training Compliance is an Increasingly Complex Journey
    • Something Good Always Comes From Something Bad
    • Leveraging the Cloud to Accelerate Time to Treatment
    • Working Towards a Glimpse of a Cure
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • World Cancer Day: Breakthroughs and Challenges for Precision Medicine
    • Surveillance or Surgery?
    • "Yes, I Can!"
    • A Biosimilar Milestone with Implications
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Effective Late Stage Pathways For Biosimilar Products
    • Biosimilar mAbs – a unique and distinct market (for the time being…?)
    • When the Doctor Becomes the Patient
    • The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
    • The Impact of the Digital Human Resources Organization on People - Part 1
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • The Journey Continues – I Got This
    • So, My Fitbit is Clinical Trial Grade Right?
    • Latin America’s Role in Clinical Studies
    • Trends in Translational Development
    • Effective use of Value to Achieve Optimal Market Access
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • The Art and Science of Productive FDA Meetings
    • Driving the Digital Transformation of the Industry
    • Regulatory Strategy In Emerging Markets
    • Exploring Our Partnership with CHA Medical Group
    • PAREXEL Introduces Jamie Macdonald as Chief Executive Officer
    • Understanding different stakeholder requirements throughout commercialization
    • Development considerations: Comparing major markets including US, EU, Japan and China
    • Risk and Common Mistakes in Import and Export Documentation for Clinical Trials
    • Operational Aspects Of Independent Reviews for Immune-Oncology Clinical Endpoints
    • PAREXEL Academy Introduces New Collaboration to Develop Japan’s Biopharmaceutical Workforce of the Future
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
    • Graduate | PAREXEL
  • Menu
Home > Company > News & Events > Press Releases > 2010 > PAREXEL EXPERTS TO ADDRESS TRE...

Archive

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000

PAREXEL EXPERTS TO ADDRESS TRENDS IN COST EFFECTIVE STUDY MANAGEMENT AND HEALTH OUTCOMES AT ISPOR ANNUAL INTERNATIONAL MEETING

Boston, MA, May 12, 2010—Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address key trends in late phase development, comparative effectiveness research, cost effective study management, and health outcomes at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 15th Annual International Meeting. During the meeting, to be held May 15 – 19, 2010 in Atlanta, PAREXEL representatives will be in attendance to discuss expertise related to all phases of clinical development, reimbursement and market access,  and medical communications. Attendees can learn more about these areas by visiting PAREXEL Booths #53 and #54 in the exhibit hall.

During the meeting, Yvonne Lis, Ph.D., Director, Health Outcomes, PAREXEL will lead the ISPOR Risk Benefit Management (RBM) Interest Group presentation “Head to Head Comparison of EMEA to U.S. RBM Guidelines Working Group,” which will be held on May 16 at 6:30 p.m. The ISPOR meeting program also features numerous poster sessions, which will be presented by PAREXEL experts, including:

  • Review of Cost Effectiveness Studies in High Budget Impact Drugs – Saurabh Aggarwal, Ph.D., Senior Consultant, Reimbursement and Market Access, PAREXEL Consulting  (Poster Session I: PMC16, May 17, 6:30 p.m. - 7:30 p.m.)
  • Tapping Into a New Data Collection Paradigm: Using Direct to Patient Programs for More Cost Effective Study Management – Ramita Tandon, Senior Director, Global Portfolio Management, Peri-Approval Services, PAREXEL(Poster Session I: PMC39, May 17, 6:30 p.m. - 7:30 p.m.)
  • A Novel Methodology for Measuring the Influence of Comorbidity in Health Outcome Studies – Victor A. Kiri, M.Sc., Ph.D., Director, Pharmacoepidemiology, Peri-Approval Services, PAREXEL (Poster Session III: PRS2, May 19, 11:45 a.m. – 12:45 p.m.)

For more information about PAREXEL visit www.PAREXEL.com or Booths #53 and #54 during the meeting. Information about the ISPOR Annual International Meeting can be found at http://www.ispor.org.

                                                                   # # #

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has approximately 9,500 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains “forward-looking” statements regarding future results and events, including, without limitation, statements regarding expected financial results, future growth and customer demand. For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “intends,” “appears,” “estimates,” “projects,” “will,” “would,” “could,” “targets,” and similar expressions are also intended to identify forward-looking statements. The forward-looking statements in this release involve a number of risks and uncertainties. The Company’s actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, including the anticipated restructuring charge of approximately $24 million over the second, third, and fourth quarters of Fiscal Year 2010; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company’s recognition of revenue included in backlog; the Company’s dependence on certain industries and clients; the Company’s ability to win new business, manage growth and costs, and attract and retain employees; the Company’s ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company’s business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks. Such factors and others are discussed more fully in the section entitled “Risk Factors” of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2010 as filed with the SEC on May 7, 2010 which “Risk Factors” discussion is incorporated by reference in this press release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.

Make part of your solution

2010

Products and Services

    RELATED CONTENT

    Linkedin Updates

    View Profile
      Warning: Invalid argument supplied for foreach() in /home/saltwater/www/www.parexel.com/site/themes/parexel-responsive/elements/footer.php on line 27

    CAREERS AT PAREXEL®

    If you are inspired to make a difference
    in the world, we can help you make it possible.

    Search job openings worldwide

    PAREXEL International Corp.
    +1 781 487 9900
    195 West Street
    Waltham, MA 02451 

    • ABOUT PAREXEL®
    • NEWS & EVENTS
    • VOLUNTEER
    • CONTACT
    • MY PAREXEL PREFERENCE CENTER
    • CLIENT LOGIN
    • LIQUENT®
    • CLINICAL TRIAL INVESTIGATOR
    • SITE MAP
    • TERMS OF SERVICE
    • PRIVACY POLICY
    • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

    Copyright ©2000-2018 PAREXEL International Corporation.